Laboratorios Farmaceuticos Rovi, S.A. Profit Margin

Laboratorios Farmaceuticos Rovi, S.A. (LABFF) currently reports a profit margin of 23.95% as of June 2026. That compares with 17.66% in the prior-year period — up 35.6% year over year. That is above the sector sector average of 13.23%. Use the charts on this page to explore Laboratorios Farmaceuticos Rovi, S.A.'s profit margin history and peer comparisons.

Laboratorios Farmaceuticos Rovi, S.A.'s profit margin increased from 17.66% to 23.95% — a 35.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Laboratorios Farmaceuticos Rovi, S.A.'s profit margin of 23.95% is higher than the its sector sector average of 13.23%. That is roughly 81.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Laboratorios Farmaceuticos Rovi, S.A.'s current 23.95% should be judged against industry norms (sector average: 13.23%) and against LABFF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 23.95%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for Laboratorios Farmaceuticos Rovi, S.A., and consider following LABFF for alerts when major investors trade the stock.